Cargando…
Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing
Bovine herpesvirus type I (BoHV-1) is an important pathogen that causes respiratory disease in bovines. The disease is prevalent worldwide, causing huge economic losses to the cattle industry. Gene-deficient vaccines with immunological markers to distinguish them from wild-type infections have becom...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029512/ https://www.ncbi.nlm.nih.gov/pubmed/35448664 http://dx.doi.org/10.3390/vetsci9040166 |
_version_ | 1784691896707186688 |
---|---|
author | Liu, Chun-Yu Jin, Ming Guo, Hao Zhao, Hong-Zhe Hou, Li-Na Yang, Yang Wen, Yong-Jun Wang, Feng-Xue |
author_facet | Liu, Chun-Yu Jin, Ming Guo, Hao Zhao, Hong-Zhe Hou, Li-Na Yang, Yang Wen, Yong-Jun Wang, Feng-Xue |
author_sort | Liu, Chun-Yu |
collection | PubMed |
description | Bovine herpesvirus type I (BoHV-1) is an important pathogen that causes respiratory disease in bovines. The disease is prevalent worldwide, causing huge economic losses to the cattle industry. Gene-deficient vaccines with immunological markers to distinguish them from wild-type infections have become a mainstream in vaccine research and development. In order to knock out the gE gene BoHV-1, we employed the CRISPR/Cas9 system. Interesting phenomena were observed at the single guide RNA (sgRNA) splicing site, including gene insertion, gene deletion, and the inversion of 5′ and 3′ ends of the sgRNA splicing site. In addition to the deletion of the gE gene, the US9 gene, and the non-coding regions of gE and US9, it was found that the US4 sequence, US6 sequence, and part of the US7 sequence were inserted into the EGFP sgRNA splicing site and the 3′ end of the EGFP sequence was deleted. Similar to the BoHV-1 parent, the BoHV-1 mutants induced high neutralizing antibodies titer levels in mice. In summary, we developed a series of recombinant gE-deletion BoHV-1 samples using the CRISPR/Cas9 gene editing system. The mutant viruses with EGFP(+) or EGFP(−) will lay the foundation for research on BoHV-1 and vaccine development in the future. |
format | Online Article Text |
id | pubmed-9029512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90295122022-04-23 Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing Liu, Chun-Yu Jin, Ming Guo, Hao Zhao, Hong-Zhe Hou, Li-Na Yang, Yang Wen, Yong-Jun Wang, Feng-Xue Vet Sci Article Bovine herpesvirus type I (BoHV-1) is an important pathogen that causes respiratory disease in bovines. The disease is prevalent worldwide, causing huge economic losses to the cattle industry. Gene-deficient vaccines with immunological markers to distinguish them from wild-type infections have become a mainstream in vaccine research and development. In order to knock out the gE gene BoHV-1, we employed the CRISPR/Cas9 system. Interesting phenomena were observed at the single guide RNA (sgRNA) splicing site, including gene insertion, gene deletion, and the inversion of 5′ and 3′ ends of the sgRNA splicing site. In addition to the deletion of the gE gene, the US9 gene, and the non-coding regions of gE and US9, it was found that the US4 sequence, US6 sequence, and part of the US7 sequence were inserted into the EGFP sgRNA splicing site and the 3′ end of the EGFP sequence was deleted. Similar to the BoHV-1 parent, the BoHV-1 mutants induced high neutralizing antibodies titer levels in mice. In summary, we developed a series of recombinant gE-deletion BoHV-1 samples using the CRISPR/Cas9 gene editing system. The mutant viruses with EGFP(+) or EGFP(−) will lay the foundation for research on BoHV-1 and vaccine development in the future. MDPI 2022-03-30 /pmc/articles/PMC9029512/ /pubmed/35448664 http://dx.doi.org/10.3390/vetsci9040166 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Chun-Yu Jin, Ming Guo, Hao Zhao, Hong-Zhe Hou, Li-Na Yang, Yang Wen, Yong-Jun Wang, Feng-Xue Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title | Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title_full | Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title_fullStr | Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title_full_unstemmed | Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title_short | Concurrent Gene Insertion, Deletion, and Inversion during the Construction of a Novel Attenuated BoHV-1 Using CRISPR/Cas9 Genome Editing |
title_sort | concurrent gene insertion, deletion, and inversion during the construction of a novel attenuated bohv-1 using crispr/cas9 genome editing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029512/ https://www.ncbi.nlm.nih.gov/pubmed/35448664 http://dx.doi.org/10.3390/vetsci9040166 |
work_keys_str_mv | AT liuchunyu concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT jinming concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT guohao concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT zhaohongzhe concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT houlina concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT yangyang concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT wenyongjun concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting AT wangfengxue concurrentgeneinsertiondeletionandinversionduringtheconstructionofanovelattenuatedbohv1usingcrisprcas9genomeediting |